期刊文献+

20(S)-原人参二醇促进CFTR氯离子通道开放 被引量:6

Natural Compound 20(S)-Protopanaxadiol Activates Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel
下载PDF
导出
摘要 利用氯离子通道细胞荧光测定模型对386种中药单体化合物进行筛选,发现20(S)-原人参二醇对依赖于cAMP的CFTR氯离子通道具有激活作用.20(S)-原人参二醇能够以剂量依赖的方式激活野生型CFTR氯离子通道,其激活作用通过更为可靠的氯离子通道短路电流测定系统得到证实.20(S)-原人参二醇对CFTR氯离子通道的激活效应具有作用迅速且可逆的特点.其在发挥激活作用时依赖于腺苷环化酶激动剂Forskolin的存在,单独与细胞孵育不提高细胞内cAMP的水平,表明对CFTR氯离子通道的激活作用是通过与CFTR直接结合实现的.该化合物对ΔF508-CFTR突变氯离子通道的开放也具有特征相似的激活作用. In the present study, we identified a natural compound 20 (S)-protopanaxadiol as an effective CFTR chloride channel activator by screening of 386 single compounds from Chinese medicinal herbs by cellbased fluorescent assay. The CFTR-stimulating activity was confirmed by an Ussing chamber short-circuit current assay. The activation is rapid, reversible and cAMP-dependent. The compound does not elevate cellular cAMP level, implying that it worked in a direct binding way. 20 (S)-Protopanaxadiol can also restore the impaired chloride conductance of AFS08 mutant CFTR. In our study a new natural compound was identified that may be useful for probing CFTR channel gating mechanisms and as a leading compound to develop pharmacological therapy of CFTR-related disease such as cystic fibrosis, idiopathic chronic pancreatitis, keratoconjunc- tivitis sicca and habitual constipation.
出处 《高等学校化学学报》 SCIE EI CAS CSCD 北大核心 2008年第4期731-735,共5页 Chemical Journal of Chinese Universities
基金 国家自然科学基金(批准号:30470405,30570864,30670477) 吉林省杰出青年基金(批准号:20030112) 教育部青年骨干教师奖励计划 留学回国人员科研基金资助
关键词 囊性纤维化 CFTR氯离子通道 突变 天然化合物 激活剂 Cystic fibrosis CFTR chloride channel Mutation Natural products Activator
  • 相关文献

参考文献12

  • 1Welsh M. J. , Smith A. E.. Cell[J] , 1993, 73:1251-1254.
  • 2Reddy M. M. , Quinton P. M.. J. Membr. Biol. [J], 2005, 207(1) : 23-33.
  • 3Schwiebert E. M. , Benos D. J. , Egan M. E. , et al.. Physiol. Rev. [JJ , 1999, 79:5145-5166.
  • 4Kunzelmann K. , Schreiber R.. J. Membr. Biol. [J] 1999, 168:1-8.
  • 5Riordan J. R., Rommens J. M., Kerem B. S., et al.. Science[J], 1989, 245:1066-1072.
  • 6Cohn J. A.. J. Clin. Gastroenterol. [J] , 2005, 39(4, Suppl. 2) : S70-S77.
  • 7Levin M. H. , Verkman A. S.. Invest. Ophthalmol. Vis. Sci. [J] , 2005, 46(4) : 1428-1434.
  • 8Morris A. P., Scott J. K., Ball J. M., et al.. Am. J. Physiol. [J], 1999, 277(2, Part 1): G431-G444.
  • 9Ma T. , Thiagarajah J. R. , Yang H. , et al.. J. Clin. Invest. [J], 2002, 110(11) : 1651-1658.
  • 10Yang H. , Shelat A. A. , Guy R. K. , et al.. J. Biol. Chem. [J], 2003, 278(37) : 35079-35085.

同被引文献82

引证文献6

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部